Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11-12
|
pubmed:dateCreated |
1988-9-22
|
pubmed:language |
hrv
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0025-8105
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
573-7
|
pubmed:dateRevised |
2009-11-9
|
pubmed:meshHeading |
pubmed-meshheading:3331415-Clinical Trials as Topic,
pubmed-meshheading:3331415-Drug Utilization,
pubmed-meshheading:3331415-Evaluation Studies as Topic,
pubmed-meshheading:3331415-Humans,
pubmed-meshheading:3331415-Patient Compliance,
pubmed-meshheading:3331415-Pharmaceutical Preparations,
pubmed-meshheading:3331415-Product Surveillance, Postmarketing,
pubmed-meshheading:3331415-Yugoslavia
|
pubmed:year |
1987
|
pubmed:articleTitle |
[Post-marketing surveillance of drugs: epidemiologic approach].
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract
|